What is NTHI's earnings growth forecast for 2026-2026?
(NASDAQ: NTHI) Neonc Technologies Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Neonc Technologies Holdings's earnings in 2026 is N/A.
In 2026, NTHI is forecast to generate -$29,398,408 in earnings, with the lowest earnings forecast at -$28,245,529 and the highest earnings forecast at -$30,263,067.
What is NTHI's revenue growth forecast for 2026-2026?
(NASDAQ: NTHI) Neonc Technologies Holdings's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Neonc Technologies Holdings's revenue in 2026 is N/A.
In 2026, NTHI is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.
What is NTHI's forecast return on assets (ROA) for 2026-2026?
(NASDAQ: NTHI) forecast ROA is -720.03%, which is lower than the forecast US Biotechnology industry average of -13.18%.
What is NTHI's Earnings Per Share (EPS) forecast for 2026-2026?
(NASDAQ: NTHI) Neonc Technologies Holdings's current Earnings Per Share (EPS) is N/A. In 2026, NTHI's EPS is forecast to hit -$1.51 (min: -$1.45, max: -$1.55).
What is NTHI's forecast return on equity (ROE) for 2026-2026?
(NASDAQ: NTHI) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.